The day's news in five stories, every morning and evening. Summarized by AI from trusted sources, so you don't have to read it all.
Business briefing · Saturday, October 24, 2026 · Morning edition · Story 4 of 5
Doctors highlight Moderna and Merck cancer vaccine progress
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent surgery. The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.
Why it matters: The vaccine's effectiveness in preventing cancer recurrence could influence future treatment options for melanoma patients.
Sources: CNBC · MarketWatch
Get the briefing by email
The day's top five stories, with the audio, in your inbox.
Science briefings are coming soon. Pick it now and we'll send it when it launches.
Email me the daily read.xyz briefing. Unsubscribe anytime. We never share or sell your address.